PA

PNK Group to Modernize Winder Factories in East Atlanta

Retrieved on: 
fredag, juni 7, 2024
Voortman, Ventilation, Engineering, Lifting, Element, PNK, Bed, Heat

PNK Group is modernizing its Winder County, Georgia plant, enhancing facilities and equipment, creating job opportunities, and improving operational efficiency, with completion expected by the end of 2024.

Key Points: 
  • Atlanta, Georgia--(Newsfile Corp. - June 6, 2024) - PNK Group is set to complete the modernization of its reinforced concrete and structural steel plant in Winder County, Georgia, within the next few months.
  • Acquired by PNK Group a year ago, the plant is expected to begin reinforced concrete production and increase steel element manufacturing by the end of 2024.
  • Strategically located within a complex of industrial buildings covering approximately 400,000 square feet on a 75-acre plot near the local airport, Winder Factories is a key asset for PNK Group.
  • PNK Group is known for its advancements in industrial construction, utilizing large-unit blocks to streamline building assembly and reduce the need for extensive labor and heavy machinery.

MONDAY DEADLINE: Berger Montague Advises AST SpaceMobile, Inc. (NASDAQ: ASTS) Investors to Inquire About a Securities Fraud Class Action by June 17, 2024

Retrieved on: 
lördag, juni 15, 2024
ASTS, Court, Investment, Bluebird, Lead, Complaint, News, AST SpaceMobile

Investors that suffered losses from AST SpaceMobile (NASDAQ: ASTS) investments can follow the link below for more information regarding the lawsuit:

Key Points: 
  • Investors that suffered losses from AST SpaceMobile (NASDAQ: ASTS) investments can follow the link below for more information regarding the lawsuit:
    CLICK HERE to learn more about the lawsuit.
  • Investors who purchased or acquired AST SpaceMobile securities during the Class Period may, no later than June 17, 2024, seek to be appointed as a lead plaintiff representative of the class.
  • The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel.
  • Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.

INVESTOR ALERT: Edelson Lechtzin LLP Urges Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Shareholders to Consult Counsel About the Pending Securities Fraud Class Action

Retrieved on: 
fredag, juni 14, 2024
Action Replay, HERE, Role, Risk, Failure, Defendant, Medication, Marinus, District court, Complaint, News, Epilepsy, Report, Pharmaceutical industry

Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] .

Key Points: 
  • Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] .
  • The lead plaintiff is a court-appointed representative of a class of purchasers of securities in a class action under the federal securities fraud laws.
  • Marinus Pharmaceuticals, headquartered in Radnor, Pennsylvania, makes and sells treatments for people with rare genetic epilepsies and other seizure disorders.
  • On this news, the price of Marinus stock fell $0.14 per share, to close at $1.43 on May 8, 2024.

INVESTOR ALERT: Edelson Lechtzin LLP Urges Hertz Global Holdings, Inc. (NASDAQ: HTZ) Shareholders to Consult Counsel About the Pending Securities Fraud Class Action

Retrieved on: 
fredag, juni 14, 2024
Action Replay, HERE, The Hertz Corporation, EVS, Role, EV, ICE, Hertz, Defendant, Depreciation, Sale, District court, Complaint, News, HTZ, Car rental

Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] .

Key Points: 
  • Please contact Edelson Lechtzin LLP at 844-696-7492 to discuss your investment losses, or by e-mail at [email protected] .
  • A copy of the class action complaint can be viewed HERE .
  • The lead plaintiff is a court-appointed representative of a class of purchasers of securities in a class action under the federal securities fraud laws.
  • On this news, Hertz’s stock price fell $1.12 per share, or 19.31%, to close at $4.68 per share on April 25, 2024.

ATTENTION NYSE: RBLX INVESTORS: Contact Berger Montague About a Roblox Corporation Class Action Lawsuit

Retrieved on: 
fredag, juni 14, 2024
Advertising, Minecraft, Court, Growth, Roblox Corporation, RBLX, Lead, Complaint, News, Music

PHILADELPHIA, June 14, 2024 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities fraud class action lawsuit has been filed against Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX) on behalf of purchasers of Roblox securities between November 15, 2023 and May 8, 2024, inclusive (the “Class Period”).

Key Points: 
  • PHILADELPHIA, June 14, 2024 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities fraud class action lawsuit has been filed against Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX) on behalf of purchasers of Roblox securities between November 15, 2023 and May 8, 2024, inclusive (the “Class Period”).
  • Investor Deadline: Investors who purchased or acquired Roblox securities during the Class Period may, no later than August 12, 2024, seek to be appointed as a lead plaintiff representative of the class.
  • Headquartered in San Mateo, California, Roblox is an online entertainment publisher and distributor, which also sells advertising space on its platforms.
  • Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.

Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors

Retrieved on: 
fredag, juni 14, 2024
AstraZeneca, Executive director, Research, Internal medicine, Reata Pharmaceuticals, Therapy, Portola Pharmaceuticals, Senior, CKD, Hypertension, Inflammation, Investment, Chronic kidney disease, Cardiology, Harvard Medical School, DSM-IV codes, CSL Vifor, Brandeis University, CSL, Pharmaceutical industry

has been appointed to the Company's Board of Directors (the Board), effective June 13, 2024.

Key Points: 
  • has been appointed to the Company's Board of Directors (the Board), effective June 13, 2024.
  • “As a cardiologist and accomplished biopharmaceutical clinical development executive, Alex brings tremendous experience driving value for biopharmaceutical companies.
  • “I look forward to working with the Company’s executive team and fellow Board members to advance the treatment of cardiorenal metabolic disorders.
  • He has held executive positions at several biopharmaceutical companies that targeted numerous therapeutic areas, including cardiometabolic, renal, and inflammation.

DOCS Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Doximity, Inc. (DOCS) Investors of Filing Deadline in Class Action Lawsuit

Retrieved on: 
fredag, juni 14, 2024
HERE, Research, THIS, Workforce, Court, LLP, Growth, Division of Tangney, COVID, District court, Lead, News

Important Deadline Reminder: Investors who purchased or otherwise acquired Doximity common stock during the Class Period may, no later than June 17, 2024, move the Court to serve as lead plaintiff for the class.

Key Points: 
  • Important Deadline Reminder: Investors who purchased or otherwise acquired Doximity common stock during the Class Period may, no later than June 17, 2024, move the Court to serve as lead plaintiff for the class.
  • If you suffered Doximity losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/doximity-inc?utm_source=PR&utm_medium=lin...
    You can also contact attorney Jonathan Naji, Esq.
  • of Kessler Topaz by calling (484) 270-1453 or by email at [email protected] .
  • Kessler Topaz Meltzer & Check, LLP encourages Doximity investors who have suffered significant losses to contact the firm directly to acquire more information.

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201

Retrieved on: 
fredag, juni 14, 2024
Congress, News, Hydroxychloroquine, SLE, Male, Tacrolimus, Patient, Immune system, Methotrexate, Cyclophosphamide, Infection, CRS, Safety, Clinical trial, Rituximab, Disease, Leukopenia, Flow cytometry, Glucocorticoid, Prednisone, Cytokine release syndrome, TIS, Immunoglobulin therapy, Belimumab, Potential, Myopathy, EULAR, Symposia, Organic acid, Pharmaceutical industry

“We are encouraged by the initial safety, clinical and translational data from the RESET-Myositis and RESET-SLE trials which we believe provide important early validation regarding the potential of the selected clinical dose of CABA-201 to enable an immune system reset for patients with autoimmune diseases.

Key Points: 
  • “We are encouraged by the initial safety, clinical and translational data from the RESET-Myositis and RESET-SLE trials which we believe provide important early validation regarding the potential of the selected clinical dose of CABA-201 to enable an immune system reset for patients with autoimmune diseases.
  • Cabaletta is advancing four Phase 1/2 RESET trials evaluating CABA-201 within a total of ten cohorts with six patients in each cohort.
  • ET to review the initial clinical data presented at the satellite symposium at the EULAR 2024 Congress and provide an update on the RESET clinical development program.
  • A webcast of the live call can be accessed on the News and Events section of the Company’s website at www.cabalettabio.com .

DEADLINE ALERT for MBUU, GL, EQIX, INTC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
fredag, juni 14, 2024
Boat, Telephone, Equinix, Culture, Growth, Foundry, Class, Investment, Law, Suite, Intel

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

Toll Brothers Apartment Living and PGIM Announce Grand Opening of The Laurent, a New Luxury Apartment Community in Cambridge, Mass.

Retrieved on: 
torsdag, juni 13, 2024
Development, Laurent, Alewife station, Wheeler Street, Cambridge, Growth, Patio, PGIM, Wells Fargo, BNY Mellon, Toll Brothers, Kendall Square

CAMBRIDGE, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living , the rental subsidiary of Toll Brothers, Inc .

Key Points: 
  • CAMBRIDGE, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living , the rental subsidiary of Toll Brothers, Inc .
  • (NYSE: TOL), the nation's leading builder of luxury homes, along with joint venture partner PGIM, announced the grand opening of The Laurent , a new seven-story, 525-unit luxury mid-rise multifamily community in Cambridge, Massachusetts.
  • "The Laurent represents our commitment to bringing luxury living to vibrant locations positioned for growth," said John McCullough, President of Toll Brothers Apartment Living.
  • "Together with our partners at PGIM, we have set a new standard of apartment living in Cambridge while expanding our footprint in the Boston area."